Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Ixekizumab Auto-Injector vs Prefilled Syringe in Plaque Psoriasis
NCT01777191Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2013
- Primary completion
- May 2014
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of ixekizumab in plaque psoriasis, sponsored by Eli Lilly and Company. Started Mar 2013; status: completed.
02
Drugs
ixekizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01777191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01777191.